Dsm-firmenich Switzerland Ag, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Royal DSM- Growth & Value: Purpose-led, Performance-driven.
One of their notable products is DEXPANTHENOL, with a corresponding US DMF Number 30723.
Remarkably, this DMF maintains an Active status since its submission on September 02, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 01, 2017, and payment made on January 09, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II